Glentis Pharma Private Limited
About Glentis Pharma Private Limited
Data last updated:
Glentis Pharma Private Limited is a private limited company based in Ranchi, Jharkhand, India. It was incorporated on 19 March 2023.
The company is registered with the Registrar of Companies (ROC), Ranchi, under CIN U46497JH2023PTC020114.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors Manisha Munda and Sunil Kujur.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ranchi, Jharkhand.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.56 Lakh. For the same year it recorded a net loss of ₹1.79 Lakh (net margin -20.9%) and EBITDA of -₹1.77 Lakh (EBITDA margin -20.7%).
Company details
Contact details
Glentis Pharma Private Limited's registered office is in Ranchi, Jharkhand.
- Registered AddressC/O Lucion Toppo Shashtri Nagar Kank, E Road U. Bzr (G. Ngr), Ranchi, Jharkhand, India – 834008
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Glentis Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Glentis Pharma Private Limited, buy the company report.
Financials of Glentis Pharma Private Limited
FY 2025 filings availableGlentis Pharma Private Limited reported revenue of ₹8.56 Lakh for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹1.77 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹1.79 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -20.7% | |
| Net Profit Margin | -20.9% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Glentis Pharma Private Limited, buy the company report.
Board of directors of Glentis Pharma Private Limited
Glentis Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manisha Munda | Director | 19 Mar 2023 | 3 Years 7 Months | Current |
| Sunil Kujur | Director | 19 Mar 2023 | 3 Years 7 Months | Current |
Peer comparison
Glentis Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Excell Formulations Private Limited | ₹8.57 Lakh (FY 2025) | -69.0% | Thane, Maharashtra, India | |||
| Theralink Pharma Private Limited | ₹8.56 Lakh (FY 2025) | Ahmedabad, Gujarat, India | ||||
| Merryclone Perfumery Private Limited | ₹8.56 Lakh (FY 2025) | 36.0% | Delhi, India | |||
| Spectomatic Private Limited | ₹8.56 Lakh (FY 2025) | 792581.0% | Mumbai, Maharashtra, India | |||
| Crescent Trexim Pvt Ltd | ₹8.56 Lakh (FY 2025) | -85.0% | Kolkata, West Bengal, India | |||
| Glentis Pharma Private Limitedthis company | ₹8.56 Lakh (FY 2024) | -₹1.79 Lakh | -20.9% | Ranchi, Jharkhand, India | ||
| HFS Marketing Solutions Private Limited | ₹8.55 Lakh (FY 2024) | -48.0% | Mumbai, Maharashtra, India | |||
| Smbdmj Private Limited | ₹8.54 Lakh (FY 2024) | Loni, Uttar Pradesh, India | ||||
| Vestergaard Frandsen (India) Private Limited | ₹8.53 Lakh (FY 2024) | -98.0% | New Delhi, Delhi, India | |||
| Anubandh Tradelink Pvt Ltd | ₹8.53 Lakh (FY 2025) | 211.0% | Kolkata, West Bengal, India | |||
| Timfany Global Private Limited | ₹8.51 Lakh (FY 2024) | 31.0% | Pune, Maharashtra, India |
To see the full peer comparison of Glentis Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Glentis Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Glentis Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Glentis Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Glentis Pharma Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Manisha Munda was appointed as Director on 19 Mar 2023.
Frequently asked questions
Glentis Pharma is an active private limited company based in Ranchi, Jharkhand, India. It was incorporated on 19 March 2023 (3+ years old) and is registered under CIN U46497JH2023PTC020114.
Glentis Pharma has 2 current directors:
- Manisha Munda - Director
- Sunil Kujur - Director
The latest financial statements of Glentis Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Glentis Pharma is U46497JH2023PTC020114. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Glentis Pharma was incorporated on 19 March 2023, making it 3+ years old. It is registered with the Registrar of Companies, Ranchi.
The peers of Glentis Pharma by revenue are Excell Formulations Private Limited, Theralink Pharma Private Limited, Merryclone Perfumery Private Limited, Spectomatic Private Limited, Crescent Trexim Pvt Ltd and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Manisha Munda was appointed as Director on 19 Mar 2023. Sunil Kujur was appointed as Director on 19 Mar 2023.
The registered office of Glentis Pharma is at CO Lucion Toppo Shashtri Nagar Kank, E Road U. Bzr G. Ngr, Ranchi, Jharkhand, India – 834008.
Glentis Pharma can be reached at its registered office: CO Lucion Toppo Shashtri Nagar Kank, E Road U. Bzr G. Ngr, Ranchi, Jharkhand, India – 834008.
Glentis Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Ranchi.